Equity Profile

RVTY

Revvity, Inc.

Health CareLife Sciences Tools & Services$13.1B

Jul27Mon

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

$1.22

Revenue

Total revenue gives insight into the company's sales performance and market demand for its products and services.

$703M

Wall Street expectations, options signals, track record, and call prep available with Pro.

RVTY Q2-2026 Earnings Preview

Context

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services. With a market cap of $13 billion, it plays a crucial role in advancing medical research and diagnostics, which is increasingly important as healthcare continues to evolve with technology.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q1 2026, Revvity reported an EPS of $1.04, slightly beating expectations. The stock reacted positively, gaining 6.69% the following day.

Management Promises & Guidance

Continue to innovate in life sciences tools.
Focus on expanding market share in key segments.
Enhance customer engagement and satisfaction.

Expectations

Wall Street Expectations

Analysts expect Revvity to report solid earnings, with a consensus EPS of $1.22 and revenue of $703 million. The market is keen to see if the company can maintain its growth trajectory.

Bull Case

If Revvity beats EPS and revenue estimates, it could signal strong demand for its products and potentially lead to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about its growth prospects, leading to a negative stock reaction.

Key Metrics to Watch

EPS

$1.22

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Revenue

$703M

Total revenue gives insight into the company's sales performance and market demand for its products and services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Revvity's EPS exceed the consensus estimate of $1.22?

A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.

What are the revenue figures compared to the consensus of $703 million?

Revenue performance is critical for assessing the company's growth and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Revvity's ability to capitalize on emerging healthcare trends, particularly in diagnostics and research tools.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational management.

Options pricing suggests higher volatility than historical averages, indicating market uncertainty.

Recent trends in healthcare spending may favor Revvity's product offerings.

Key Risk

If revenue growth significantly outpaces expectations, it could shift market sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be pivotal in determining whether Revvity can sustain its growth amidst increasing competition in the healthcare sector.

Bull Confirmed If

An EPS of $1.25 or higher would confirm strong operational performance.

Bear Confirmed If

An EPS below $1.19 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±5.73%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a move of about 5.73%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±5.7% while RVTY has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

50.1%

Calls (5K)P/C Ratio: 1.43Puts (800)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations, history suggests a potential stock increase of around 0.94% on the following day, confirming strong demand.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors assess future growth prospects.

Miss

A miss could lead to a decline, with historical data suggesting an average drop of 0.94% when expectations are not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on revenue.
2Any commentary on market share gains in key segments.
3Insights into customer engagement strategies and their effectiveness.
4Management's outlook on industry trends and competitive landscape.
5Details on cost management initiatives and their impact on margins.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aon plc

Company Snapshot

Revvity, Inc. is a healthcare company focused on life sciences tools and services....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

$1.22

Revenue

Total revenue gives insight into the company's sales performance and market demand for its products and services.

$703M

Wall Street expectations, options signals, track record, and call prep available with Pro.

RVTY Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+6.07%

Avg Stock Reaction

+0.94%

Last Quarter Recap

In Q1 2026, Revvity reported an EPS of $1.04, slightly beating expectations. The stock reacted positively, gaining 6.69% the following day.

Management Promises & Guidance

Continue to innovate in life sciences tools.
Focus on expanding market share in key segments.
Enhance customer engagement and satisfaction.

Expectations

Wall Street Expectations

Analysts expect Revvity to report solid earnings, with a consensus EPS of $1.22 and revenue of $703 million. The market is keen to see if the company can maintain its growth trajectory.

Bull Case

If Revvity beats EPS and revenue estimates, it could signal strong demand for its products and potentially lead to a positive stock reaction.

Bear Case

Conversely, if the company fails to meet expectations, it may raise concerns about its growth prospects, leading to a negative stock reaction.

Key Metrics to Watch

EPS

$1.22

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating income.

Revenue

$703M

Total revenue gives insight into the company's sales performance and market demand for its products and services.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will Revvity's EPS exceed the consensus estimate of $1.22?

A beat on EPS could reinforce investor confidence and lead to a positive stock reaction.

What are the revenue figures compared to the consensus of $703 million?

Revenue performance is critical for assessing the company's growth and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Revvity's ability to capitalize on emerging healthcare trends, particularly in diagnostics and research tools.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational management.

Options pricing suggests higher volatility than historical averages, indicating market uncertainty.

Recent trends in healthcare spending may favor Revvity's product offerings.

Key Risk

If revenue growth significantly outpaces expectations, it could shift market sentiment positively.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results will be pivotal in determining whether Revvity can sustain its growth amidst increasing competition in the healthcare sector.

Bull Confirmed If

An EPS of $1.25 or higher would confirm strong operational performance.

Bear Confirmed If

An EPS below $1.19 would raise concerns about the company's growth trajectory.

Pre-Earnings Positioning

Options Market

Implied Move

±5.73%

Historical Avg

±4.0%

Pricing rich

The options market is pricing in a move of about 5.73%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±5.7% while RVTY has averaged ±4.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

50.1%

Calls (5K)P/C Ratio: 1.43Puts (800)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Revvity beats expectations, history suggests a potential stock increase of around 0.94% on the following day, confirming strong demand.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors assess future growth prospects.

Miss

A miss could lead to a decline, with historical data suggesting an average drop of 0.94% when expectations are not met.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on revenue.
2Any commentary on market share gains in key segments.
3Insights into customer engagement strategies and their effectiveness.
4Management's outlook on industry trends and competitive landscape.
5Details on cost management initiatives and their impact on margins.